One of a kind Oncologist newsletter

Oncotarget is a company based on oncological research. Since, its formation, the company has been working to bring innovations in the field of oncology to introduce better treatments and drugs for cancer patients. Oncotarget is basically a newsletter that works on peer to peer review. People from anywhere can share their research work on oncology in this newsletter and can share their knowledge with others. It provides doctors from all over the world a platform to share their work. It is a way of connecting doctors who can interact with each other and can get benefit from each other’s research work. In this way, they make sure they can help the cancer patients in every possible way.

The first newsletter was published by Oncotarget in 2010. Since then it has gained a lot of attention and praise among its readers. Its huge success is due to the fact that it is for doctors and by doctors. That is why it is greatly appreciated by doctors specifically oncologists. These doctors are highly experienced treating patients for many years. They are also aware of the new treatments and innovations in the technology for treatment. Mr. Andrei Gudkov and Mikhail Blagosklonny are its owners. They are highly qualified researchers in the field of oncology and have made incredible progress. Their experience and knowledge have helped them to establish a highly effective newsletter on oncology. The newsletter grew fast in oncology under the guidance of both these men.

This newsletter is weekly and allows open access to all kinds of readers who want to get informed about the latest technologies in the field of oncology or who want to publish their work in oncology. The newsletter is run by two well-known oncologists has attracted the attention of a wide variety of readers all around the world. This has helped a lot in oncology, from discoveries to new treatments and drugs, now many patients can be saved with greater ease. The death of patients suffering from cancer has greatly reduced with the help of this newsletter and to know more click here

 


Comments are closed.